Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)

NCT01082510 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

288

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Bacille Calmette-Guerin
DRUG: uracil-tegafur

Sponsor

Urological Oncology Council of Northern Tokyo